Perry Carter Caviness, DrPH

Affiliate Member

Research Program:

Cancer Therapeutics

Faculty Rank:

Staff Scientist

Campus:

University of Arkansas for Medical Sciences

College:

College of Medicine

Department:

Biochemistry & Molecular Biology

Cancer Research Interest

Disease Site Focus: No Specific Disease Site
Research Focus Area: Treatment, Detection, Diagnosis/ Prognosis
Type of Research: Translational, Clinical
Research Interest Statement: My work as a High-throughput screening staff scientist in the Screening and Drug Discovery resource at the Cancer institute allows me to work on a multitude of projects focused on identifying novel compound leads that could be developed into potential cancer treatment options. As such my interests are focused on the identification of new compounds that target cancer cells and the translational process to develop said compounds into treatment options.

Gai D, Caviness PC, Lazarenko OP, [et al.]. Cystatin M/E Ameliorates Multiple Myeloma-Induced Hyper Osteolytic Bone Resorption. Cancers. 2025 17(5). PMID: 40075680. PMCID: PMC11899016.
Caviness PC, Lazarenko OP, Blackburn ML, [et al.]. Phenolic acids prevent sex-steroid deficiency-induced bone loss and bone marrow adipogenesis in mice. The Journal of nutritional biochemistry. 2024 127:109601. PMID: 38367948.
Caviness PC, Gai D, Lazarenko OP, [et al.]. Decreased bone resorption in Ezh2 myeloid cell conditional knockout mouse model. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2023 37(7):e23019. PMID: 37272906.